SIMR Biotechnology
- Biotech or pharma, therapeutic R&D
A biotech dedicated to innovative drug development for pain, inflammatory, and nerve system relate diseases. Looking for partners to out-license our first-in-class assets for pain (Ph2), DME/DR, pneumonia (Ph2 stage),and Alzheimer’s disease (Ph1).